
Zomedica President Larry Heaton outlined plans to reach more veterinary clinics and shorten sales cycles, focusing on faster demo-to-purchase conversions.
Zomedica President Larry Heaton used the company's Friday afternoon investor webinar to detail how the veterinary diagnostics firm plans to expand its customer base and shorten the sales cycle.
Heaton said the company is targeting a broader set of veterinary practices, not just the largest specialty hospitals. The strategy involves a more focused sales pitch around Zomedica's point-of-care diagnostic tools, which allow vets to run tests in-house rather than sending samples to reference labs. The goal is to get more vets to trial the equipment and then convert those trials into recurring consumables revenue.
"The execution piece is about making sure our sales team can demonstrate value quickly," Heaton said during the call. He noted that the company has been refining its training and support materials to reduce the time between a first demo and a purchase order.
Zomedica has historically relied on a direct sales force. Heaton said the company is also exploring partnerships with distribution networks that already call on smaller clinics, a channel that could broaden reach without adding fixed cost.
The webinar, part of Zomedica's "Fourth Friday at Four" series, did not include new financial guidance or product launches. Shares of Zomedica trade over the counter under the ticker ZOMDF.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.